Startup commercializing VU IP to reduce injury, death and mitigate $50BN annual medical spend.
Nondilutive capital gives entrepreneurs advantages in research, bizdev and raising capital.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: